View
Page
RNS: Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept. Expected but good to see another one going through, augurs well for the rst of the development pipeline. Getting nearer to commercialiasation when it will be possible to put a more precise valuation on the business. NB Neil Woodford owns 6.7% in his new fund.
Latest from the Community...
Latest from the Community...
Latest from the Community...